The many faces of intraperitoneal chemotherapy
- 1 March 2022
- journal article
- review article
- Published by Elsevier in Surgical Oncology
- Vol. 40, 101676
Abstract
No abstract availableKeywords
This publication has 69 references indexed in Scilit:
- Definition of Patients Presenting a High Risk of Developing Peritoneal Carcinomatosis After Curative Surgery for Colorectal Cancer: A Systematic ReviewAnnals of Surgical Oncology, 2012
- HIPEC for Peritoneal Carcinomatosis: Does an Associated Urologic Procedure Increase Morbidity?Annals of Surgical Oncology, 2011
- Toward curative treatment of peritoneal carcinomatosis from nonovarian origin by cytoreductive surgery combined with perioperative intraperitoneal chemotherapyCancer, 2010
- Hyperthermic intraperitoneal chemotherapy: Rationale and techniqueWorld Journal of Gastrointestinal Oncology, 2010
- Impact of the Peritoneal Surface Disease Severity Score on Survival in Patients with Colorectal Cancer Peritoneal Carcinomatosis Undergoing Complete Cytoreduction and Hyperthermic Intraperitoneal ChemotherapyAnnals of Surgical Oncology, 2009
- Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Malignant Peritoneal Mesothelioma: Multi-Institutional ExperienceJournal of Clinical Oncology, 2009
- Technology of Hyperthermic Intraperitoneal Chemotherapy in the United States, Europe, China, Japan, and KoreaThe Cancer Journal, 2009
- Pharmacokinetics and Pharmacodynamics of Perioperative Cancer Chemotherapy in Peritoneal Surface MalignancyThe Cancer Journal, 2009
- Hyperthermic intraperitoneal chemotherapy: Nomenclature and modalities of perfusionJournal of Surgical Oncology, 2008
- Dissection by electrocautery with a ball tipJournal of Surgical Oncology, 1994